• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

川崎病患者长期管理指南。美国心脏协会青少年心血管疾病理事会风湿热、心内膜炎和川崎病委员会报告。

Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

作者信息

Dajani A S, Taubert K A, Takahashi M, Bierman F Z, Freed M D, Ferrieri P, Gerber M, Shulman S T, Karchmer A W, Wilson W

机构信息

Office of Scientific Affairs, American Heart Association, Dallas, TX 75231-4596.

出版信息

Circulation. 1994 Feb;89(2):916-22. doi: 10.1161/01.cir.89.2.916.

DOI:10.1161/01.cir.89.2.916
PMID:8313588
Abstract

Long-term management of patients with Kawasaki disease should be tailored to the degree of coronary arterial involvement. This committee has made recommendations for each risk level about antiplatelet and anticoagulant therapy, physical activity, follow-up assessment by a pediatric cardiologist or primary care physician, and the appropriate diagnostic procedures that may be performed to evaluate cardiac disease. The risk level for a given patient with coronary arterial involvement may change over time because of changes in coronary artery morphology. The recommendations for management presented here are intended as practical interim guidelines until additional prospective or retrospective data are compiled to define more clearly the natural history of Kawasaki disease.

摘要

川崎病患者的长期管理应根据冠状动脉受累程度进行调整。本委员会已针对每个风险水平就抗血小板和抗凝治疗、体育活动、由儿科心脏病专家或初级保健医生进行的随访评估以及为评估心脏疾病可能进行的适当诊断程序提出了建议。由于冠状动脉形态的变化,特定冠状动脉受累患者的风险水平可能会随时间而改变。此处提出的管理建议旨在作为实用的临时指南,直至收集到更多前瞻性或回顾性数据以更清楚地界定川崎病的自然病程。

相似文献

1
Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.川崎病患者长期管理指南。美国心脏协会青少年心血管疾病理事会风湿热、心内膜炎和川崎病委员会报告。
Circulation. 1994 Feb;89(2):916-22. doi: 10.1161/01.cir.89.2.916.
2
Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.川崎病的诊断、治疗及长期管理:美国心脏协会青少年心血管疾病理事会风湿热、心内膜炎及川崎病委员会为卫生专业人员发布的声明
Pediatrics. 2004 Dec;114(6):1708-33. doi: 10.1542/peds.2004-2182.
3
Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.川崎病的诊断、治疗及长期管理:美国心脏协会青少年心血管疾病理事会风湿热、心内膜炎及川崎病委员会给卫生专业人员的声明
Circulation. 2004 Oct 26;110(17):2747-71. doi: 10.1161/01.CIR.0000145143.19711.78.
4
Guidelines for long-term management of patients with Kawasaki disease. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.川崎病患者长期管理指南。美国心脏协会青年心血管疾病理事会风湿热、心内膜炎和川崎病委员会制定
Heart Dis Stroke. 1994 May-Jun;3(3):169-70.
5
Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group.感染性心内膜炎的预防:美国心脏协会指南:美国心脏协会风湿热、心内膜炎及川崎病委员会、青年心血管疾病理事会、临床心脏病学理事会、心血管外科和麻醉理事会以及医疗质量与结果研究跨学科工作组制定的指南
Circulation. 2007 Oct 9;116(15):1736-54. doi: 10.1161/CIRCULATIONAHA.106.183095. Epub 2007 Apr 19.
6
Diagnostic guidelines for Kawasaki disease. American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease.川崎病诊断指南。美国心脏协会风湿热、心内膜炎及川崎病委员会
Am J Dis Child. 1990 Nov;144(11):1218-9.
7
Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America.感染性心内膜炎:诊断、抗菌治疗及并发症管理:美国心脏协会风湿热、心内膜炎及川崎病委员会、青年心血管疾病理事会以及临床心脏病学、中风、心血管外科和麻醉理事会为医疗专业人员发布的声明:获美国传染病学会认可
Circulation. 2005 Jun 14;111(23):e394-434. doi: 10.1161/CIRCULATIONAHA.105.165564.
8
[Recommendations for clinical management of Kawasaki disease with coronary arterial lesions].[川崎病合并冠状动脉病变的临床管理建议]
Zhonghua Er Ke Za Zhi. 2012 Oct;50(10):746-9.
9
A national survey on the pediatric cardiologist's clinical approach for patients with Kawasaki disease.一项关于儿科心脏病专家对川崎病患者临床治疗方法的全国性调查。
Pediatr Cardiol. 2002 Nov-Dec;23(6):639-46. doi: 10.1007/s00246-001-9070-x.
10
[Kawasaki disease: interdisciplinary and intersocieties consensus (clinical guidelines). Brief version].[川崎病:跨学科和跨学会共识(临床指南)。简版]
Arch Argent Pediatr. 2016 Aug 1;114(4):385-90. doi: 10.5546/aap.2016.385.

引用本文的文献

1
Thrombelastogram are associated with coronary artery aneurysm in Kawasaki disease patients.血栓弹力图与川崎病患者的冠状动脉瘤有关。
BMC Cardiovasc Disord. 2025 Jul 3;25(1):444. doi: 10.1186/s12872-025-04903-5.
2
Systemic Arterial Aneurysms in Kawasaki Disease: An Important Evidence Gap.川崎病中的系统性动脉动脉瘤:一个重要的证据空白。
Pediatr Cardiol. 2025 May 12. doi: 10.1007/s00246-025-03888-4.
3
Brazilian Guideline for Exercise Testing in Children and Adolescents - 2024.巴西儿童和青少年运动测试指南-2024 年版。
Arq Bras Cardiol. 2024 Sep 16;121(8):e20240525. doi: 10.36660/abc.20240525.
4
Late onset Kawasaki disease with multiple coronary arterial aneurysms: A case report.迟发性川崎病合并多发冠状动脉瘤:一例报告
Radiol Case Rep. 2024 Aug 10;19(11):4762-4765. doi: 10.1016/j.radcr.2024.07.066. eCollection 2024 Nov.
5
Risk factors and coronary artery outcomes of coronary artery aneurysms differing in size and emergence time in children with Kawasaki disease.川崎病患儿不同大小和出现时间的冠状动脉瘤的危险因素及冠状动脉结局
Front Cardiovasc Med. 2022 Sep 9;9:969495. doi: 10.3389/fcvm.2022.969495. eCollection 2022.
6
SCMR expert consensus statement for cardiovascular magnetic resonance of acquired and non-structural pediatric heart disease.SCMR 专家共识声明:获得性和非结构性儿科心脏病的心血管磁共振成像。
J Cardiovasc Magn Reson. 2022 Jul 21;24(1):44. doi: 10.1186/s12968-022-00873-1.
7
COVID-19 related multisystem inflammatory syndrome in children (MIS-C): a hospital-based prospective cohort study from Kerala, India.儿童 COVID-19 相关多系统炎症综合征 (MIS-C):来自印度喀拉拉邦的一项基于医院的前瞻性队列研究。
BMJ Paediatr Open. 2021 Oct 18;5(1):e001195. doi: 10.1136/bmjpo-2021-001195. eCollection 2021.
8
Kawasaki Disease- Management Strategies Given Symptoms Overlap to COVID-19: A Review.川崎病-鉴于症状与 COVID-19 重叠的管理策略:综述。
JNMA J Nepal Med Assoc. 2021 Apr 30;59(236):417-424. doi: 10.31729/jnma.5698.
9
Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.Pentraxin 3 水平升高与川崎病对 IVIG 的反应性和冠状动脉瘤形成相关。
Front Immunol. 2021 Apr 12;12:624802. doi: 10.3389/fimmu.2021.624802. eCollection 2021.
10
Effect of Early Intravenous Immunoglobulin Therapy in Kawasaki Disease: A Systematic Review and Meta-Analysis.早期静脉注射免疫球蛋白治疗川崎病的效果:一项系统评价与荟萃分析
Front Pediatr. 2020 Nov 20;8:593435. doi: 10.3389/fped.2020.593435. eCollection 2020.